PharmGKB summary

This publication has 60 references indexed in Scilit:

• HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
  New England Journal of Medicine, 2011
• The IMGT/HLA database
  Nucleic Acids Research, 2010
• Model-Based Approach To Characterize Efavirenz Autoinduction and Concurrent Enzyme Induction with Carbamazepine
  Antimicrobial Agents and Chemotherapy, 2009
• Pathways of Carbamazepine Bioactivation in Vitro. III. The Role of Human Cytochrome P450 Enzymes in the Formation of 2,3-Dihydroxycarbamazepine
  Drug Metabolism and Disposition, 2008
• CYP3A4-Mediated Carbamazepine (CBZ) Metabolism: Formation of a Covalent CBZ-CYP3A4 Adduct and Alteration of the Enzyme Kinetic Profile
  Drug Metabolism and Disposition, 2008
• Mutation of sodium channel SCN3A in a patient with cryptogenic pediatric partial epilepsy
  Neuroscience Letters, 2008
• Nova2 Interacts with a Cis-Acting Polymorphism to Influence the Proportions of Drug-Responsive Splice Variants of SCN1A
  The American Journal of Human Genetics, 2007
• A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC
  Nature Genetics, 2006
• Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions
  Pharmacogenetics and Genomics, 2006
• Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk.
  Journal of Clinical Investigation, 1988